Mr Daniel Donauer > MLL Legal > Zurich, Switzerland > Lawyer Profile

MLL Legal
SCHIFFBAUSTRASSE 2
POSTFACH
8031 ZÜRICH
Switzerland

Position

Daniel Donauer is an attorney in the firm’s Zurich office and a member of the Product Regulation, Intellectual Property and Litigation & Arbitration practice groups.

Career

Daniel Donauer’s practice focuses on matters in the life sciences sector. In this context, he advises his clients on both regulatory and litigation issues of health care and medical law, in particular on product regulation and product implementation for pharmaceuticals and medicinal products, medical devices, food, alcohol and tobacco products, consumer goods (i.e., cosmetics, human contact articles, etc.) as well as chemicals, and handles matters in the area of advertising law. In addition, he advises and litigates in intellectual property matters. A particular focus of his advice lies in the area of health insurance law as well as in the area of care law. Furthermore, he assists clients with medical law matters in the area of human research, reproductive medicine or genetic engineering and advises on medical professionals’ law as well as physician and patient law.

Languages

German, English

Memberships

Zurich Bar Association (ZAV), Swiss Bar Association (SAV)

Education

University of Zurich, CAS Medical Law (2021), University of Washington, USA (Health Law), LL.M. (2020), University of Lucerne, Dr. iur. (2018), Admitted to the bar in Switzerland (2016), University of Berne, MLaw (2013)

Lawyer Rankings

Switzerland > Public law

(Rising stars)

Daniel Donauer  – MLL Legal

MLL Legal’s practice group has extensive experience in the production and distribution of a range of regulated products, including pharmaceuticals, medical products, tobacco and cosmetics. The team regularly advises and represents clients on all public procurement matters. The team is co-headed by Simon Holzer, who has extensive expertise in the pharmaceutical sector, and Michael Reinle, who advises clients in the software, IT, and telecoms industries. Kilian Schärli has a special focus on blockchain pharmaceutical use cases and transactions in the life sciences sector. Daniel Donauer, who was promoted to senior associate in 2023, has expertise in the implementation and regulation of cosmetics, alcohol, tobacco and therapeutic products.